Overview
Hongyu Liu practices in Tianjin, China. Liu is highly rated in 7 conditions, according to our data. Their top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma.
Their clinical research consists of co-authoring 140 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerLiu isDistinguished. Learn about Lung Cancer.
- Advanced
- Cerebral HypoxiaLiu isAdvanced. Learn about Cerebral Hypoxia.
- Large-Cell Lung Carcinoma
- Lung AdenocarcinomaLiu isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma
- Experienced
- AsthmaLiu isExperienced. Learn about Asthma.
- Ear CancerLiu isExperienced. Learn about Ear Cancer.
- EGFR Positive Lung CancerLiu isExperienced. Learn about EGFR Positive Lung Cancer.
- GliomaLiu isExperienced. Learn about Glioma.
- Lung MetastasesLiu isExperienced. Learn about Lung Metastases.
- LymphangioleiomyomatosisLiu isExperienced. Learn about Lymphangioleiomyomatosis.